Company research
Avricore Health Inc.
CIK 1355736Updated Sep 25, 2026
SecuritiesAVCRF · OTC · equityAVCR · TSXV · equity
Name history
Vanc Pharmaceuticals Inc. · through Oct 5, 2018NUVA Pharmaceuticals Inc. · through Jun 17, 2014ALDA Pharmaceuticals Corp. · through Oct 29, 2013
AVCRF price & chart
Loading TradingView…
OTC:AVCRF on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2024 · CADSource
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossCAD | -668,977Source | -701,215Source | -818,228Source | -1,708,132Source |
| Additional Financial Items | ||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableCAD | 8,102Source | 338,090Source | -687,492Source | 79,620Source |
| AdjustmentsForFinanceCostsCAD | — | — | — | 38,438Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableCAD | -158,401Source | 176,325Source | 268,416Source | -69,592Source |
| AdjustmentsForSharebasedPaymentsCAD | 541,164Source | 703,612Source | 331,522Source | 495,791Source |
| GeneralAndAdministrativeExpenseCAD | 409,398Source | 339,369Source | 250,144Source | 183,000Source |
| ProceedsFromIssuingSharesCAD | — | — | — | 2,404,000Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesCAD | 24,253Source | 25,288Source | 5,171Source | 35,006Source |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesCAD | — | — | — | 1,000,000Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | — |
| Total Revenue | — | — | — | — |
| Additional Financial Items | ||||
| ApplicableTaxRatenumber | — | — | 0.27Source | 0.27Source |
| BasicEarningsLossPerShareCAD/shares | -0.01Source | -0.01Source | -0.01Source | -0.02Source |
| DepreciationAndAmortisationExpenseCAD | 3,137Source | 2,347Source | 631Source | 17,984Source |
| DilutedEarningsLossPerShareCAD/shares | -0.01Source | -0.01Source | — | — |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesCAD | 541,164Source | 703,612Source | 331,522Source | 495,791Source |
| FinanceCostsCAD | — | — | — | 38,438Source |
| GeneralAndAdministrativeExpenseCAD | 409,398Source | 339,369Source | 250,144Source | 183,000Source |
| GrossProfitCAD | 1,880,287Source | 1,203,396Source | 456,793Source | 30,521Source |
| InterestExpenseCAD | — | — | — | 21,096Source |
| ProfessionalFeesExpenseCAD | 255,655Source | 285,935Source | 150,585Source | 189,796Source |
| ProfitLossBeforeTaxCAD | 129,001Source | -693,253Source | — | — |
| RevenueFromInterestCAD | 1,235Source | 3,284Source | 8,086Source | 581Source |